Wikidata

(Q39406065)

English

CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.

scientific article published on 25 January 2012

In more languages

Statements

title
CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22278419
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22278419%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 January 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39406065&oldid=1843943801"